TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant,

James Chih-Hsin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.